On November 11, 2020 CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high unmet need, reported that management will participate in three virtual investor conferences including Stifel 2020 Virtual Healthcare Conference taking place November 16-19, 2020, the Evercore ISI 3rd Annual HealthCONx Conference taking place December 1-3, 2020, and the Piper Sandler 32nd Annual Virtual Healthcare Conference taking place December 1- 3, 2020 (Press release, CymaBay Therapeutics, NOV 11, 2020, View Source [SID1234570564]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Stifel’s 2020 Virtual Healthcare Conference
Date: Tuesday, November 17
Time: 1:20 pm Eastern Time
Webcast: View Source

Evercore ISI 3rd Annual HealthCONx Conference
Date: Tuesday, December 1
Time: 3:55 pm Eastern Time / Track 4
Webcast: View Source

Piper Sandler 32nd Annual Virtual Healthcare Conference
Date: Thursday, December 3, 2020
Time: 9:00 am Eastern Time
Webcast: View Source